A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Recent Hologic Acquisition Bolder Surgical Included on Fast Company’s Annual List of World’s Most Innovative Companies

Company Recognized for Pioneering Advanced Energy Vessel Sealing Surgical Devices, Including Hologic's CoolSeal® Vessel Sealing Portfolio

What To Know

  • Hologic's surgical product line also includes the NovaSure® endometrial ablation system for the treatment of abnormal uterine bleeding, the MyoSure® tissue removal devices for the removal of intrauterine fibroids and polyps, the Acessa® laparoscopic radiofrequency ablation system for the treatment of fibroids, and the Fluent® fluid management system for streamlining hysteroscopic procedures.
  • “We’re thrilled that Bolder — the newest member of our Surgical business — has captured a spot on Fast Company’s prestigious list of the most innovative companies making an impact around the globe,”.

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that recently acquired Bolder Surgical was included on Fast Company’s annual list of the World’s Most Innovative Companies. Bolder Surgical, a developer and manufacturer of advanced energy vessel sealing and dissection tools for surgical gynecologists in both laparoscopic and open procedures was acquired by Hologic in November 2021.

Hologic notes Bolder ranked fifth on the list of Most Innovative Medical Device Companies, a sector highlighting companies that are creatively using technology to improve patient care. The full list of Most Innovative Companies consisted of 528 companies chosen by a team of editors and reporters for Fast Company from thousands of applicants across the globe.

“We’re thrilled that Bolder — the newest member of our Surgical business — has captured a spot on Fast Company’s prestigious list of the most innovative companies making an impact around the globe,” said Essex Mitchell, Hologic’s Division President, Surgical. “The CoolSeal devices have already proven to be an important addition to our growing Surgical portfolio, and we’re looking forward to seeing how we can continue to improve efficiency for surgeons and hospitals, while helping to improve outcomes for patients, through these innovative products.”

Bolder was recognized for its innovation in designing surgical devices, in particular the CoolSeal® devices, which allows for dissection, vessel sealing and dividing all in one tool. The ability to use a combination device improves surgical efficiency by reducing the need for instrument exchanges. In addition, Bolder’s CoolSeal® Mini 3 mm vessel sealer and the JustRight® 5 mm stapler are designed for small surgical spaces such as in pediatric cases, which can help reduce the need for larger, overpowered instruments.

Hologic’s surgical product line also includes the NovaSure® endometrial ablation system for the treatment of abnormal uterine bleeding, the MyoSure® tissue removal devices for the removal of intrauterine fibroids and polyps, the Acessa® laparoscopic radiofrequency ablation system for the treatment of fibroids, and the Fluent® fluid management system for streamlining hysteroscopic procedures.

According to Fast Company, the Most Innovative Companies list “has been the definitive source for recognizing the organizations that are transforming industries and shaping society” since it began in 2008.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.
SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.

By using this website you agree to accept Medical Device News Magazine Privacy Policy